Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.

Hein DW, Leff MA, Ishibe N, Sinha R, Frazier HA, Doll MA, Xiao GH, Weinrich MC, Caporaso NE.

Environ Mol Mutagen. 2002;40(3):161-7.

PMID:
12355549
3.

Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1.

Fretland AJ, Doll MA, Leff MA, Hein DW.

Pharmacogenetics. 2001 Aug;11(6):511-20.

PMID:
11505221
4.

Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms.

Fretland AJ, Leff MA, Doll MA, Hein DW.

Pharmacogenetics. 2001 Apr;11(3):207-15.

PMID:
11337936
5.

DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine.

Fretland AJ, Devanaboyina US, Nangju NA, Leff MA, Xiao GH, Webb SJ, Doll MA, Hein DW.

J Biochem Mol Toxicol. 2001;15(1):26-33.

PMID:
11170312
6.
7.

N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.

Deitz AC, Zheng W, Leff MA, Gross M, Wen WQ, Doll MA, Xiao GH, Folsom AR, Hein DW.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):905-10.

8.

Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y.

Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Review.

9.

Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype.

Leff MA, Fretland AJ, Doll MA, Hein DW.

J Biol Chem. 1999 Dec 3;274(49):34519-22.

10.

Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.

Leff MA, Epstein PN, Doll MA, Fretland AJ, Devanaboyina US, Rustan TD, Hein DW.

J Pharmacol Exp Ther. 1999 Jul;290(1):182-7.

PMID:
10381774
11.

Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression.

Krumenacker JS, Buckley DJ, Leff MA, McCormack JT, de Jong G, Gout PW, Reed JC, Miyashita T, Magnuson NS, Buckley AR.

Endocrine. 1998 Oct;9(2):163-70.

PMID:
9867250
12.

Butyrate-induced reversal of dexamethasone resistance in autonomous rat Nb2 lymphoma cells.

Buckley AR, Krumenacker JS, Buckley DJ, Leff MA, Magnuson NS, Reed JC, Miyashita T, de Jong G, Gout PW.

Apoptosis. 1997;2(6):518-28.

PMID:
14646523
13.

Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.

Buckley AR, Leff MA, Buckley DJ, Magnuson NS, de Jong G, Gout PW.

Cell Growth Differ. 1996 Dec;7(12):1713-21.

14.

Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells.

Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR.

Endocrinology. 1996 Dec;137(12):5456-62.

PMID:
8940371
15.

Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells.

Buckley AR, Buckley DJ, Leff MA, Hoover DS, Magnuson NS.

Endocrinology. 1995 Dec;136(12):5252-9.

PMID:
7588268

Supplemental Content

Support Center